Zobrazeno 1 - 10
of 112
pro vyhledávání: '"Pierre Yves Dumas"'
Autor:
Céline Row, Nicolas Lechevalier, Jean Philippe Vial, Aguirre Mimoun, Jean Noel Bastie, Ingrid Lafon, Arnaud Pigneux, Thibaut Leguay, Mary Callanan, Marc Maynadie, Marie C. Béné, Pierre Yves Dumas, Julien Guy
Publikováno v:
eJHaem, Vol 5, Iss 1, Pp 84-92 (2024)
Abstract Risk stratification and treatment response evaluation are key features in acute myeloid leukemia (AML) management. Immunophenotypic and molecular approaches all rely on the detection of persisting leukemic cells by measurable residual diseas
Externí odkaz:
https://doaj.org/article/1139eebd20364c2d82e6aaf440adc0a1
Autor:
Michael Mounie, Pierre-Yves Dumas, Sandra Liva-Yonnet, Didier Fabre, Thibault Leguay, Jean Galtier, Emilie Berard, Ramaroson Hanta, Véronique Gilleron, Sarah Bertoli, Arnaud Pigneux, Christian Récher, Nadège Costa
Publikováno v:
Blood Cancer Journal, Vol 13, Iss 1, Pp 1-4 (2023)
Externí odkaz:
https://doaj.org/article/d61964e43f6c4c59b75f86c3de4abaa5
Autor:
Louise Laloi, Natacha Chaumard Billotey, Pierre‐Yves Dumas, Franciane Paul, Alban Villate, Célestine Simand, Luc Fornecker, Florent Puisset, Sarah Bertoli, Marion Boissard Simonet, Kamel Laribi, Dyhia Houyou, Alberto Santagostino, Claire Michel, Gabrielle Roth Guepin, Elodie Guerineau, Reza Tabrizi, Mathilde Hunault, Aurélien Giltat, Eléonore Kaphan, Claude Bulabois, Elodie Cartet, Clément Rocher, Florence Lachenal, Stéphane Morisset, Christian Récher, Arnaud Pigneux, Amine Belhabri, Mauricette Michallet, Anne‐Sophie Michallet
Publikováno v:
Cancer Medicine, Vol 12, Iss 6, Pp 7175-7181 (2023)
Abstract Background Recently, the combination of venetoclax plus a hypomethylating agent (HMA; azacitidine ordecitabine) or low‐dose cytarabine (LDAC) showed promise in Phase III trials in previously untreated AML. In France at the time of this stu
Externí odkaz:
https://doaj.org/article/63f3a6ecd43b4f86b0b0537085a06afc
Autor:
François Vergez, Laetitia Largeaud, Sarah Bertoli, Marie-Laure Nicolau, Jean-Baptiste Rieu, Inès Vergnolle, Estelle Saland, Audrey Sarry, Suzanne Tavitian, Françoise Huguet, Muriel Picard, Jean-Philippe Vial, Nicolas Lechevalier, Audrey Bidet, Pierre-Yves Dumas, Arnaud Pigneux, Isabelle Luquet, Véronique Mansat-De Mas, Eric Delabesse, Martin Carroll, Gwenn Danet-Desnoyers, Jean-Emmanuel Sarry, Christian Récher
Publikováno v:
Blood Cancer Journal, Vol 12, Iss 8, Pp 1-11 (2022)
Abstract Classifications of acute myeloid leukemia (AML) patients rely on morphologic, cytogenetic, and molecular features. Here we have established a novel flow cytometry-based immunophenotypic stratification showing that AML blasts are blocked at s
Externí odkaz:
https://doaj.org/article/d9e29c225e7649168cd1370ebb1c8953
Autor:
Emilie Bérard, Christoph Röllig, Sarah Bertoli, Arnaud Pigneux, Suzanne Tavitian, Michael Kramer, Hubert Serve, Martin Bornhäuser, Uwe Platzbecker, Carsten Müller-Tidow, Claudia D. Baldus, David Martínez-Cuadrón, Josefina Serrano, Pilar Martínez-Sánchez, Eduardo Rodríguez Arbolí, Cristina Gil, Juan Bergua, Teresa Bernal, Adolfo de la Fuente Burguera, Eric Delabesse, Audrey Bidet, Pierre-Yves Dumas, Pau Montesinos, Christian Récher
Publikováno v:
Blood Cancer Journal, Vol 12, Iss 7, Pp 1-8 (2022)
Abstract In a context of therapeutic revolution in older adults with AML, it is becoming increasingly important to select patients for the various treatment options by taking account of short-term efficacy and toxicity as well as long-term survival.
Externí odkaz:
https://doaj.org/article/a79de68b14424fe89380e50d0b454990
Autor:
Charles Dussiau, Henry Dupuy, Audrey Bidet, Mathieu Sauvezie, Anne-Charlotte De-Grande, Lisa Boureau, Etienne Riviere, Edouard Forcade, Fabrice Bonnet, Pierre-Yves Dumas, Pierre Duffau, Arnaud Pigneux, Jean-François Viallard, Sophie Dimicoli-Salazar, Estibaliz Lazaro
Publikováno v:
HemaSphere, Vol 7, Iss 3, p e847 (2023)
Externí odkaz:
https://doaj.org/article/b3908326221d4d42971c62cd4cbf9b37
Autor:
Jean Galtier, Camille Alric, Emilie Bérard, Thibaut Leguay, Suzanne Tavitian, Audrey Bidet, Eric Delabesse, Jean Baptiste Rieu, Jean-Philippe Vial, François Vergez, Nicolas Lechevalier, Isabelle Luquet, Emilie Klein, Anne-Charlotte de Grande, Audrey Sarry, Arnaud Pigneux, Christian Récher, Sarah Bertoli, Pierre-Yves Dumas
Publikováno v:
Blood Cancer Journal, Vol 11, Iss 11, Pp 1-4 (2021)
Externí odkaz:
https://doaj.org/article/f96185a801b446e9a88718b9b046da3a
Autor:
Pierre‐Yves Dumas, Emilie Bérard, Claire Bréal, Stéphanie Dulucq, Delphine Réa, Franck Nicolini, Edouard Forcade, Melody Dufossée, Jean‐Max Pasquet, Béatrice Turcq, Audrey Bidet, Noel Milpied, Julie Déchanet‐Merville, Xavier Lafarge, Gabriel Etienne, François‐Xavier Mahon, French Intergroup in Chronic Myeloid Leukemia
Publikováno v:
Cancer Medicine, Vol 8, Iss 11, Pp 4976-4985 (2019)
Abstract Background Natural Killer (NK) cells are innate lymphoid cells that can be cytotoxic toward a large panel of solid tumors and hematological malignancies including chronic myeloid leukemia (CML). Such a cytotoxicity depends on various recepto
Externí odkaz:
https://doaj.org/article/fde024de99b941a08e4dd670a8681016
Autor:
Pierre-Yves Dumas, Olivier Mansier, Valerie Prouzet-Mauleon, Junji Koya, Arnaud Villacreces, Philippe Brunet de la Grange, Damien Luque Paz, Audrey Bidet, Jean-Max Pasquet, Vincent Praloran, Franck Salin, Mineo Kurokawa, François-Xavier Mahon, Bruno Cardinaud, Eric Lippert
Publikováno v:
BMC Cancer, Vol 18, Iss 1, Pp 1-11 (2018)
Abstract Background Atypical Myeloproliferative Neoplasms (aMPN) share characteristics of MPN and Myelodysplastic Syndromes. Although abnormalities in cytokine signaling are common in MPN, the pathophysiology of atypical MPN still remains elusive. Si
Externí odkaz:
https://doaj.org/article/4794d25d55f54eb09f7966c3979775b0
Autor:
Pierre-Yves Dumas, Arnaud Pigneux
Publikováno v:
Bulletin du Cancer. 110:424-432